pre-IPO PHARMA

tempest-therapeutics PRESS RELEASE ARCHIVE

Jul 12, 2021

Thinking about buying stock in Tempest Therapeutics, Cemtrex, Exela Technologies, Aethlon Medical, or Bridgeline Digital?


May 16, 2019

Tempest Therapeutics Starts Phase I/Ib Clinical Trial with First-in-Class PPAR Alpha Antagonist


Nov 13, 2018

Tempest Therapeutics Reports Proof of Mechanism Data for First-in-Class PPAR Alpha Antagonist


Sep 4, 2018

Tempest Therapeutics Names Dr. Ginna Laport CMO


Mar 28, 2018

Tempest Therapeutics Closes $70 Million Series B Financing



Google Analytics Alternative